Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.890
-0.100 (-5.03%)
At close: Jun 5, 2026, 4:00 PM EDT
1.880
-0.010 (-0.53%)
After-hours: Jun 5, 2026, 7:00 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $80.4 million as of June 5, 2026. Its market cap has increased by 105.28% in one year.
Market Cap
80.40M
Enterprise Value
60.87M
1-Year Change
105.28%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $80.40M, an increase of 28.63%. That is a compound annual growth rate of 4.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 80.40M | -12.32% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 83.15M |
| Rani Therapeutics Holdings | 82.79M |
| MAIA Biotechnology | 82.69M |
| ProMIS Neurosciences | 81.88M |
| Lixte Biotechnology Holdings | 81.33M |
| Heron Therapeutics | 80.90M |
| Aardvark Therapeutics | 80.28M |
| OS Therapies | 79.28M |